Pricing Log in Create free account

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) vs Matinas Biopharma Holdings, Inc. (MTNB)

Biodexa Pharmaceuticals PLC Unsponsored ADR and Matinas Biopharma Holdings, Inc. are both Biotechnology companies. Biodexa Pharmaceuticals PLC Unsponsored ADR and Matinas Biopharma Holdings, Inc. are of similar size ($1.3M and $1.1M). Matinas Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 2,135.9% against 60.2%. Matinas Biopharma Holdings, Inc. has the higher net margin (0.00% vs −1,155.7%) and the lower return on invested capital (−419.3% vs 0.00%). Across the 14 metrics below, Biodexa Pharmaceuticals PLC Unsponsored ADR leads on 9 and Matinas Biopharma Holdings, Inc. on 5.

Valuation

Metric BDRX MTNB Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.12 9.40
P/B n/m 0.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.20 0.04 0.66
EV/Sales (2.81) (0.06) 9.02
Earnings yield (102.95%) (1,403.30%) (32.88%)
Free cash flow yield 0.00% (1,142.24%) (23.13%)

Profitability

Metric BDRX MTNB Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin (1,155.70%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (154.28%) (51.96%)
Return on assets 0.00% (98.53%) (46.06%)
Return on invested capital 0.00% (419.27%) 0.00%

Growth

Metric BDRX MTNB Biotechnology median
Revenue growth (TTM) 60.22% 2,135.91% 6.76%
EPS growth (last fiscal year) 89.62% 59.84% 29.88%
Revenue growth, 5-year CAGR (28.78%) 55.69% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDRX MTNB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.41 0.85 4.97
Net debt to EBITDA 1.00 0.62 1.01

Dividend

Metric BDRX MTNB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BDRX MTNB Biotechnology median
Market cap 1.25m 1.14m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack